Alternate Synthesis of Apixaban (BMS-562247), an Inhibitor of Blood Coagulation Factor Xa
Authors:
- 5 September 2012
- journal article
- research article
- Published by Taylor & Francis in Synthetic Communications
- Vol. 43 (1) , 72-79
Abstract
An alternate approach to apixaban was described. The synthesis features a novel and cost-effective synthetic strategy to construct a key N-phenylvalerolactam intermediate 4 from 4-nitroaniline. In addition, the modified synthetic route avoids the use of expensive reagents and significantly improves reaction yields. As demonstrated practically, apixaban was successfully synthesized in overall good yield (35%).Keywords
This publication has 10 references indexed in Scilit:
- Effect of the Direct Factor Xa Inhibitor Apixaban in Rat Models of Thrombosis and HemostasisJournal of Cardiovascular Pharmacology, 2010
- Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndromeThrombosis and Haemostasis, 2010
- Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombinThrombosis and Haemostasis, 2010
- Molecular design of pyrazolo[3,4-d]pyridazinesRussian Journal of Organic Chemistry, 2008
- Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging studyJournal of Thrombosis and Haemostasis, 2008
- Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor XaJournal of Medicinal Chemistry, 2007
- Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic DiseasesArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Synthesis and characterization of a new trans-2,2′-azoquinoxaline bridged bisphthalocyanineTetrahedron Letters, 2005
- Liquid‐Liquid‐Liquid Phase Transfer Catalysis: A Novel and Green Concept for Selective Reduction of Substituted NitroaromaticsAdvanced Synthesis & Catalysis, 2005
- Synthesis and evaluation of furan, thiophene, and azole bis[(carbamoyloxy)methyl] derivatives as potential antineoplastic agentsJournal of Medicinal Chemistry, 1984